Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Chief Financial Officer bought 900 shares at $5.50 ($4,950)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Director sold 3,000 shares at $4.60 ($13,800)
  4. 4 Shares withheld for taxes VP and Chief Compliance Office gave up 3,840 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 7,296 shares (to pay taxes)
  6. 4 Shares withheld for taxes Sr VP/Chief Commercial Officer gave up 3,960 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chairman and CEO gave up 3,802 shares (to pay taxes)
  8. 4 Open-market sale Director sold 3,000 shares at $4.55 ($13,650)
  9. 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
  10. 4 Grant or award Sr VP/Chief Commercial Officer acquired 4,000 shares (grant or award)
  11. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  12. 4 Grant or award VP and Chief Compliance Office acquired 2,750 shares (grant or award)
  13. 4 Grant or award SVP and Chief Development Off. acquired 5,000 shares (grant or award)
  14. 4 Grant or award Director acquired 1,000 shares (grant or award)
  15. 4 Grant or award Director acquired 1,000 shares (grant or award)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Grant or award Director acquired 1,000 shares (grant or award)
  18. 4 Open-market sale Director sold 5,000 shares at $4.34 ($21,700)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 19 of 26 · 512 filings